{"id":441390,"date":"2021-02-22T20:20:01","date_gmt":"2021-02-23T01:20:01","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441390"},"modified":"2021-02-22T20:20:01","modified_gmt":"2021-02-23T01:20:01","slug":"investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/","title":{"rendered":"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors"},"content":{"rendered":"

<\/p>\n

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors<\/b><\/p>\n

BENSALEM, Pa.–(BUSINESS WIRE<\/a>)–
\nLaw Offices of Howard G. Smith announces an investigation on behalf of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the \u201cCompany\u201d) (NASDAQ: IMVT<\/a>) investors concerning the Company\u2019s possible violations of federal securities laws.\n<\/p>\n

\nOn February 2, 2021, the Company issued a press release \u201cannounc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401.\u201d The Company also disclosed that it \u201chas become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients\u201d and \u201c[o]ut of an abundance of caution, the Company has decided to voluntarily pause dosing in ongoing clinical studies in both TED and in [WAIHA], in order to inform patients, investigators, and regulators as well as to modify the monitoring program.\u201d\n<\/p>\n

\nOn this news, the Company\u2019s stock price fell $18.22 per share, or 42.08%, to close at $25.08 per share on February 2, 2021, thereby injuring investors.\n<\/p>\n

\nIf you purchased the Company\u2019s securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com<\/a>, or visit our website at www.howardsmithlaw.com<\/a>.\n<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210222005985\/en\/<\/a><\/span><\/p>\n

\nLaw Offices of Howard G. Smith
\n
Howard G. Smith, Esquire
\n
215-638-4847
\n
888-638-4847
\n
howardsmith@howardsmithlaw.com
\n<\/a>
www.howardsmithlaw.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California Pennsylvania<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors BENSALEM, Pa.–(BUSINESS WIRE)– Law Offices of Howard G. Smith announces an investigation on behalf of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the \u201cCompany\u201d) (NASDAQ: IMVT) investors concerning the Company\u2019s possible violations of federal securities laws. On February 2, 2021, the Company issued a press release \u201cannounc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401.\u201d The Company also disclosed that it \u201chas become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients\u201d and \u201c[o]ut of an abundance of caution, the Company … <\/p>\n

Continue reading “INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441390","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors BENSALEM, Pa.–(BUSINESS WIRE)– Law Offices of Howard G. Smith announces an investigation on behalf of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the \u201cCompany\u201d) (NASDAQ: IMVT) investors concerning the Company\u2019s possible violations of federal securities laws. On February 2, 2021, the Company issued a press release \u201cannounc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401.\u201d The Company also disclosed that it \u201chas become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients\u201d and \u201c[o]ut of an abundance of caution, the Company … Continue reading "INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T01:20:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\\\/k\\\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors\",\"datePublished\":\"2021-02-23T01:20:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/\",\"name\":\"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\\\/k\\\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-02-23T01:20:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\\\/k\\\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors - Market Newsdesk","og_description":"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors BENSALEM, Pa.–(BUSINESS WIRE)– Law Offices of Howard G. Smith announces an investigation on behalf of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the \u201cCompany\u201d) (NASDAQ: IMVT) investors concerning the Company\u2019s possible violations of federal securities laws. On February 2, 2021, the Company issued a press release \u201cannounc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401.\u201d The Company also disclosed that it \u201chas become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients\u201d and \u201c[o]ut of an abundance of caution, the Company … Continue reading \"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T01:20:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors","datePublished":"2021-02-23T01:20:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/"},"wordCount":347,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/","name":"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-02-23T01:20:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210222005985r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-law-offices-of-howard-g-smith-announces-investigation-of-immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-imvt-on-behalf-of-investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Immunovant, Inc. f\/k\/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441390"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441390\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}